4
Changes in Ownership
Contineum Therapeutics, Inc. Filed Acc 0001628280-26-047058
Chief Scientific Officer sold 37,179 shares at an average $15.99 ($594,578)
- Chief Scientific Officer acquired 33,009 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Loading xslF345X06/wk-form4_1783028831.xml…